Skip to content

Study Details

NFX-179: A Study Drug for Cutaneous Neurofibromas

(IRB#: IRB_00147755)

NFX-179 Gel is a study drug to reduce the growth of benign tumors that grow from small nerves under the skin called cutaneous neurofibromas (cNF). Scientists and doctors do not know the safety and effectiveness of the treatment. Research is needed to learn if it may be approved and used to improve the health of people suffering from cNF.

I AM INTERESTED

  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Ages 18+
  • All genders
  • In-person at Unversity of Utah
  • Time commitment approx. 8 months
  • Compensation up to $675

Exclusion Criteria

  • Pregnant women

Will I be paid for my time?

Yes

For more information contact:

Carrie Bailey

ped_mgr@hsc.utah.edu

  801 587 3605

IRB#: IRB_00147755

PI: David Viskochil

Department: DERMATOLOGY

Approval Date: 2022-02-02 07:00:00

Specialties: Pediatric Genetics

Last Updated: 6/8/23